{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T07:13:07Z","timestamp":1714029187662},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1177,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/j.1365-2230.2012.04399.x","type":"journal-article","created":{"date-parts":[[2012,6,11]],"date-time":"2012-06-11T10:11:31Z","timestamp":1339409491000},"page":"47-49","source":"Crossref","is-referenced-by-count":2,"title":["Synchronous melanoma and renal carcinoma: a clinicopathological study of five cases"],"prefix":"10.1093","volume":"38","author":[{"given":"R. N.","family":"Matin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Szlosarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"McGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Cerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2012,6,11]]},"reference":[{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1046\/j.1365-2133.2001.04507.x","article-title":"Risk of second primary malignancies in patients with cutaneous melanoma","volume":"145","author":"Schmid-Wendtner","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/annonc\/mdn054","article-title":"A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer","volume":"19","author":"Brown","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/1097-0142(19910801)68:3<660::AID-CNCR2820680337>3.0.CO;2-5","article-title":"Are malignant melanoma patients at higher risk for a second cancer?","volume":"68","author":"Gutman","year":"1991","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaad.2009.07.039","article-title":"Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study","volume":"62","author":"Spanogle","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","article-title":"Increased risk of second primary cancers after a diagnosis of melanoma","volume":"146","author":"Bradford","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/CMR.0b013e3282fafd0a","article-title":"The risk of developing a second, different, cancer among 14 560 survivors of malignant cutaneous melanoma: a study by AIRTUM","volume":"18","author":"Crocetti","year":"2008","journal-title":"Melanoma Res"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0022-5347(05)67892-5","article-title":"Renal cell carcinoma: prognostic significance of incidentally detected tumors","volume":"163","author":"Tsui","year":"2000","journal-title":"J Urol"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1002\/cncr.25562","article-title":"Characteristics of the coexistence of melanoma and renal cell carcinoma","volume":"116","author":"Maubec","year":"2010","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.eururo.2011.05.031","article-title":"Familial renal cell carcinoma from the Swedish Family-Cancer Database","volume":"60","author":"Liu","year":"2011","journal-title":"Eur Urol"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1158\/1078-0432.CCR-08-0403","article-title":"Increased risk of cancer other than melanoma in CDKN2A founder mutation-positive melanoma families","volume":"14","author":"de","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.urolonc.2007.05.026","article-title":"Surveillance for renal cell carcinoma. Why? How? When? How often?","volume":"26","author":"Klatte","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2133.2010.09883.x","article-title":"Revised U.K. guidelines for the management of cutaneous melanoma 2010","volume":"163","author":"Marsden","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2230.2012.04399.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1111\/j.1464-410X.2008.07847.x","article-title":"Prognostic variables to predict cancer-related death in incidental renal tumours","volume":"102","author":"Bensalah","year":"2008","journal-title":"BJU Int"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2012.04399.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2012.04399.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T06:29:12Z","timestamp":1714026552000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/38\/1\/47\/6622744"}},"subtitle":["Melanoma and renal carcinoma"],"short-title":[],"issued":{"date-parts":[[2012,6,11]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2012.04399.x","relation":{},"ISSN":["0307-6938"],"issn-type":[{"value":"0307-6938","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6,11]]}}}